|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0205099,
umls-concept:C0205171,
umls-concept:C0205210,
umls-concept:C0936012,
umls-concept:C1180419,
umls-concept:C1274040,
umls-concept:C1441672,
umls-concept:C1524063,
umls-concept:C1527178,
umls-concept:C1536696,
umls-concept:C1705938
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-2-22
|
|
pubmed:abstractText |
This study aimed to assess the resource utilisation, health benefits and cost-effectiveness of intra-detrusor injections of botulinum neurotoxin-A (BoNT/A) in patients with overactive bladder (OAB).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
519-27
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16413656-Adult,
pubmed-meshheading:16413656-Aged,
pubmed-meshheading:16413656-Aged, 80 and over,
pubmed-meshheading:16413656-Botulinum Toxins, Type A,
pubmed-meshheading:16413656-Cost-Benefit Analysis,
pubmed-meshheading:16413656-Female,
pubmed-meshheading:16413656-Great Britain,
pubmed-meshheading:16413656-Humans,
pubmed-meshheading:16413656-Injections, Intramuscular,
pubmed-meshheading:16413656-Male,
pubmed-meshheading:16413656-Middle Aged,
pubmed-meshheading:16413656-Muscle, Smooth,
pubmed-meshheading:16413656-Neuromuscular Agents,
pubmed-meshheading:16413656-Urinary Incontinence
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre.
|
|
pubmed:affiliation |
The National Hospital for Neurology and Neurosurgery, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
